Brief: Spark Therapeutics Ends Agreement With Combigene

Larkberget AB

16/10/2023 06:41

Oct 16 (Reuters) - Combigene AB  COMBI.ST :
    * SAID ON SATURDAY SPARK THERAPEUTICS TERMINATED
COLLABORATION
AGREEMENT FOR EPILEPSY PROJECT CG01 WITH COMBIGENE
    * COMBIGENE WILL REGAIN GLOBAL RIGHTS FOR EPILEPSY PROJECT
CG01
FROM SPARK THERAPEUTICS BY JAN 12, 2024
    * WAS ENTITLED TO RECEIVE UP TO $328.5 MLN EXCLUDING
ROYALTIES
    * COMBIGENE IS NOT ACCOUNTABLE FOR $8.5 MLN FROM SPARK
THERAPEUTICS, MINUS DEVELOPMENT COSTS, AND WILL NOT RECEIVE
FUTURE EARNINGS OR ROYALTIES

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN53R8DL
 Further company coverage:  COMBI.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))